- About FSPH
- Current Students
- Prospective Students
- Alumni Affairs
- Give to the School
|Departments||Type of Faculty|
Prof. Kalantar has conducted research and presented numerous grand rounds and other lectures in national and international conferences on kidney disease outcome and epidemiology, cardiovascular risks in CKD, malnutrition and wasting in chronic diseases, inflammation and cachexia, diabetes and obesity, renal osteodystrophy and mineral disorders, sodium and potassium disarrays, anemia and iron deficiency, disparities and quality of life in CKD, and acid-base disorders.
Prof. Kamyar Kalantar-Zadeh, (a.k.a. Kam Kalantar) studied medicine at the Universities of Bonn and Nuremberg in Germany and also obtained MPH and PhD degrees in Epidemiology from University of California Berkeley. His post-graduate trainings include a medicine/pediatrics residency at SUNY Brooklyn program and a Nephrology fellowship at UCSF. During 2000-2012 Dr. Kalantar served as a faculty nephrologist at Harbor-UCLA and was appointed as Professor of Medicine, Pediatrics and Epidemiology at UCLA David Geffen School of Medicine and Fielding School of Public Health. Since August 2012, Dr. Kalantar has served as the chief of the Division of Nephrology and Hypertension at UC Irvine and oversees educational programs at UC Irvine Medical Center and Long Beach Veteran Administration Medical Center. Prof. Kalantar-Zadeh is triple board certified in Internal Medicine, Pediatrics and Nephrology and has been listed in several prestigious top-physician directories including TOP DOCTORS, BEST DOCTORS, and TOP PHYSICIANS.
Please check with the faculty member or their office about availability to serve during current academic period.
Kalantar-Zadeh K, Streja E, Kovesdy CP, Noori N, Oreopoulos A, Jing J, Nissenson AR, Krishnan M, Kopple JD, Mehrotra R, Anker SD Obesity Paradox and Mortality-Predictability of Surrogates of Body Size and Muscle Mass in Hemodialysis Patients . Mayo Clinic Proc 2010; (85): 991-1001.
Kovesdy CP, Ahmadzadeh S, Anderson JE, and Kalantar-Zadeh K Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008; 168(4): 397-403.
Kalantar-Zadeh K, Regidor DL, Shinaberger CS, Jing J, Aronovitz J, McAllister CJ, Whellan D, Sharma K Hemoglobin A1c and survival in hemodialysis patients. Diabetes Care 2007; (30): 1049-55.
Kalantar-Zadeh Kamyar, Amin Alpesh N Toward more accurate detection and risk stratification of chronic kidney disease.. JAMA : the journal of the American Medical Association. 2012; 307(18): 1976-7.
Kalantar-Zadeh Kamyar, Streja Elani, Molnar Miklos Z, Lukowsky Lilia R, Krishnan Mahesh, Kovesdy Csaba P, Greenland Sander Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.. American journal of epidemiology. 2012; 175(8): 793-803.
Kovesdy Csaba P, Kalantar-Zadeh Kamyar Enter the dragon: a Chinese epidemic of chronic kidney disease?. Lancet. 2012; 379(9818): 783-5.
Ricks Joni, Molnar Miklos Z, Kovesdy Csaba P, Shah Anuja, Nissenson Allen R, Williams Mark, Kalantar-Zadeh Kamyar Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study.. Diabetes. 2012; 61(3): 708-15.
Kovesdy Csaba P, Lott Evan H, Lu Jun Ling, Malakauskas Sandra M, Ma Jennie Z, Molnar Miklos Z, Kalantar-Zadeh Kamyar Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.. Circulation. 2012; 125(5): 677-84.
Kalantar-Zadeh Kamyar, Miller Jessica E, Kovesdy Csaba P, Mehrotra Rajnish, Lukowsky Lilia R, Streja Elani, Ricks Joni, Jing Jennie, Nissenson Allen R, Greenland Sander, Norris Keith C Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2010; 25(12): 2724-34.